Feeding The Alzheimer’S Encephalon - An Innovative Approach To Treating Alzheimer’S
Alzheimer’s affects the agency the encephalon uses glucose; as well as the encephalon requires lots of break energy to business office properly.
Glucose, a type of sugar, is the brain’s primary fuel source.
From studying encephalon scans, researchers conduct hold established that inward Alzheimer’s disease, encephalon cells no longer purpose glucose usually fifty-fifty if in that location is plenty glucose available inward the body. This alter inward the brain’s might to purpose glucose, known equally glucose hypometabolism, most oftentimes occurs inward the areas of the encephalon involved inward retention as well as thinking.
Glucose hypometabolism may survive i of the earliest encephalon changes that occurs inward Alzheimer’s, showtime years, sometimes decades earlier whatsoever symptoms of the affliction appear.
In the NOURISH AD study, doctors desire to acquire if increasing ketones inward the trunk amongst an investigational novel drug tin tending retention as well as thinking skills inward people amongst Alzheimer’s disease.
Substances called ketone bodies tin likewise fuel the brain’s activities. When availability of glucose is depression inward the body, such equally during fasting, the liver naturally produces ketone bodies from fatty stores equally an alternative fuel source for the brain.
Ketone bodies tin render upwards to 60% of the brain’s break energy needs. However, the body’s production of ketone bodies stops when normal eating resumes. The trunk cannot growth ketone trunk production without really strict diet changes that are hard to grapple as well as keep long term, peculiarly for people amongst Alzheimer’s disease.
In the NOURISH AD study, doctors desire to acquire if increasing ketones inward the trunk amongst an investigational novel drug tin tending retention as well as thinking skills inward people amongst Alzheimer’s disease. Want to acquire to a greater extent than nearly this clinical inquiry study?
You tin telephone telephone straight at 1-866-503-6006 (in the U.S.)
Or, you lot tin click on the picture to function to a greater extent than data nearly this clinical trial.
The NOURISH AD Trial is straightaway opened upwards as well as recruiting novel patients. NOURISH AD is a clinical inquiry written report evaluating the security as well as effectiveness of an investigational drug for mild to moderate Alzheimer’s disease.
If you lot are interested inward finding out if your loved i qualifies to participate for this clinical case telephone telephone 866 503 6006, or view www.AD-Trial.com today!
Study volunteers must encounter the next criteria to enroll:
You are reading master content the
Glucose, a type of sugar, is the brain’s primary fuel source.
From studying encephalon scans, researchers conduct hold established that inward Alzheimer’s disease, encephalon cells no longer purpose glucose usually fifty-fifty if in that location is plenty glucose available inward the body. This alter inward the brain’s might to purpose glucose, known equally glucose hypometabolism, most oftentimes occurs inward the areas of the encephalon involved inward retention as well as thinking.
Baca Juga
Glucose hypometabolism may survive i of the earliest encephalon changes that occurs inward Alzheimer’s, showtime years, sometimes decades earlier whatsoever symptoms of the affliction appear.
In the NOURISH AD study, doctors desire to acquire if increasing ketones inward the trunk amongst an investigational novel drug tin tending retention as well as thinking skills inward people amongst Alzheimer’s disease.
Ketone bodies are the brain’s natural back-up fuel
Substances called ketone bodies tin likewise fuel the brain’s activities. When availability of glucose is depression inward the body, such equally during fasting, the liver naturally produces ketone bodies from fatty stores equally an alternative fuel source for the brain.
Ketone bodies tin render upwards to 60% of the brain’s break energy needs. However, the body’s production of ketone bodies stops when normal eating resumes. The trunk cannot growth ketone trunk production without really strict diet changes that are hard to grapple as well as keep long term, peculiarly for people amongst Alzheimer’s disease.
Investigational drug provides ketone bodies
In the NOURISH AD study, doctors desire to acquire if increasing ketones inward the trunk amongst an investigational novel drug tin tending retention as well as thinking skills inward people amongst Alzheimer’s disease. Want to acquire to a greater extent than nearly this clinical inquiry study?
You tin telephone telephone straight at 1-866-503-6006 (in the U.S.)
Or, you lot tin click on the picture to function to a greater extent than data nearly this clinical trial.
The NOURISH AD Trial is straightaway opened upwards as well as recruiting novel patients. NOURISH AD is a clinical inquiry written report evaluating the security as well as effectiveness of an investigational drug for mild to moderate Alzheimer’s disease.
If you lot are interested inward finding out if your loved i qualifies to participate for this clinical case telephone telephone 866 503 6006, or view www.AD-Trial.com today!
Study volunteers must encounter the next criteria to enroll:
- Be betwixt the ages of 66-90
- Have mild to moderate Alzheimer’s affliction or retention loss
- Have a written report partner who tin attend written report visits
- Other criteria apply
- All study-related medicines as well as consultations specific to the written report volition survive gratuitous of accuse as well as compensation for go may survive available
- Participants may proceed on their electrical flow AD medications
- Health insurance is non required to participate inward this study
- Participants may tending to advance a potential novel handling for mild to moderate Alzheimer’s disease
- 5 written report visits as well as iii telephone visits over only about vii months
- All eligible participants volition have either written report drug or placebo for 26 weeks. The written report is blinded, as well as then neither you lot nor the written report staff volition know what the player is taking.
- After completion of the 26-week blinded study, participants volition conduct hold the chance to accept component inward an optional 26-week extension written report where all participants have written report drug
- Participants may proceed to consider their regular doc field participating inward this study
You are reading master content the
